Use and Out‐of‐Pocket Cost of Sacubitril‐Valsartan in Patients With Heart Failure

BACKGROUND: Current guidelines recommend use of sacubitril‐valsartan in patients with heart failure with reduced ejection fraction (HFrEF). Early data suggested low uptake of sacubitril‐valsartan, but contemporary data on real‐world use and their associated cost are limited. METHODS AND RESULTS: Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shore, Supriya, Basu, Tanima, Kamdar, Neil, Brady, Patrick, Birati, Edo, Hummel, Scott L., Chopra, Vineet, Nallamothu, Brahmajee K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496420/
https://www.ncbi.nlm.nih.gov/pubmed/36000415
http://dx.doi.org/10.1161/JAHA.121.023950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496420/
https://www.ncbi.nlm.nih.gov/pubmed/36000415
http://dx.doi.org/10.1161/JAHA.121.023950

Ejemplares similares